In support of this concept are observations that exogenous AAT administration can protect against endotoxemia [16], pulmonary inflammation [26], [27], graft vs. host disease [18], as well as ischemic renal damage [20]. This evidence concerns the gene SERPINA1 and serum lipopolysaccharide activity.